Supporting World-Leading Genomics Researchers
McGuinty Government Fosters Breakthroughs In Health Science
Ontario is supporting research that could uncover cures for diseases like cancer while ushering in a new era of personalized medicine.
Through the Global Leadership Round in Genomics & Life Sciences (GL2), Ontario is contributing $11.5 million to support Dr. Mick Bhatia and his team of researchers at McMaster University, who are developing stem cell-based therapies. These therapies could be used as a "tool kit" to repair damage caused by cancer and other serious diseases.
The GL2 fund will support the work of more than 230 researchers taking part in 19 projects at eight research institutions across the province. GL2 will also help create jobs for graduate students, post-doctoral fellows, research assistants, associates and technicians from across Canada and abroad.
Funding world-class research is part of Ontario's Innovation Agenda to make innovation a driving force of Ontario's economy, and supports the new Open Ontario Plan to build new opportunities for growth and jobs.
- Genomics studies the complete genome (or DNA sequence) of an organism.
- Ontario is committing a total of almost $115 million under the GL2 fund, which is part of the Ontario Research Fund.
- Between 2005 and 2008, Ontario investments in research and innovation leveraged $1.1 billion while helping advance the knowledge, skills and training of close to 30,000 individuals.
“The revolutionary GL2 research projects are being led by some of the greatest minds in our province. Supporting this advanced work will drive the future of health care and promote jobs and prosperity in Ontario.”
“Hamilton is home to world-leading researchers, and we are proud to be helping McMaster make the discoveries that will lead to better lives for Ontario families.”